Literature DB >> 3582601

Relative antigenicity in mice of H1N1, H3N2 and B strains present in inactivated influenza virus vaccines.

M L Profeta, M Ruggeri.   

Abstract

The results of a study on serum HAI and neutralizing antibodies induced in mice by whole influenza virus vaccines containing A/Brazil/11/78 (H1N1), A/Bangkok/1/79 (H3N2) and B/Singapore/222/79 viruses are reported. According to the GMT of HAI, the antigenic potency of the three vaccine strains appear to be different. The A/Brazil/11/78 antigen induced the lowest HAI antibody responses and the A/Bangkok/1/79 antigen the greatest. This behaviour, with a few exceptions, was noted regardless of the HA amount (0.08 microgram 0.4 microgram, 2 micrograms) of each strain present in the vaccine, the number of doses (one or two), or the kind of preparation (monovalent or trivalent). The data obtained with the neutralization test with vaccines with medium HA content are concordant with previous findings. On the basis of the ratios of the GMT of the neutralizing antibodies to the GMT of the HAI antibodies, it was concluded that the HAI antibodies to A/Bangkok/1/79 antigen possess, on the whole, a neutralizing activity that is higher than that found for the HAI antibodies to A/Brazil/11/78 and B/Singapore/222/79 strains. For the latter strains, the neutralizing activity increased after the second dose. The observation of the different degrees of antigenicity of the three vaccine strains suggests that, with currently used inactivated influenza virus vaccines containing equivalent amounts of all three antigens, the dosage should be taken into consideration when the vaccines are used for subjects lacking in previous exposure to vaccine strains.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3582601     DOI: 10.1007/bf00145074

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  20 in total

1.  Is bivalent binding of monoclonal antibodies to different antigenic areas on the hemagglutinin of influenza virus required for neutralization of viral infectivity?

Authors:  S Yoden; H Kida; R Yanagawa
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

Review 2.  Vaccination against influenza A.

Authors:  D A Tyrrell; J W Smith
Journal:  Br Med Bull       Date:  1979-01       Impact factor: 4.291

3.  Comparative antigenicity and immunogenicity of 1976 influenza virus vaccines: results of mouse protection experiments.

Authors:  C McLaren; M S Williams; F M Bozeman; R E Mayner; G E Grubbs; W E Barthlow; E Staton; F A Ennis
Journal:  J Biol Stand       Date:  1978-10

4.  Relative immunogenicity of the cold-adapted influenza virus A/Ann Arbor/6/60 (A/AA/6/60-ca), recombinants of A/AA/6/60-ca, and parental strains with similar surface antigens.

Authors:  G A Tannock; J A Paul; R D Barry
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

5.  Correlation of laboratory studies with clinical responses to A/New Jersey influenza vaccines.

Authors:  F A Ennis; R E Mayner; D W Barry; J E Manischewitz; R C Dunlap; M W Verbonitz; R M Bozeman; G C Schild
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

6.  Cold-adapted recombinant influenza A virus vaccines in seronegative young children.

Authors:  P F Wright; N Okabe; K T McKee; H F Maassab; D T Karzon
Journal:  J Infect Dis       Date:  1982-07       Impact factor: 5.226

7.  Host defenses against influenza virus: the role of anti-hemagglutinin antibody.

Authors:  J L Virelizier
Journal:  J Immunol       Date:  1975-08       Impact factor: 5.422

8.  [Neutralizing and inhibiting activity of hemagglutination of serum antibodies after natural infection and after vaccination with influenza virus A/USSR/90/77 (H1N1) strain].

Authors:  M L Profeta; G Nardi
Journal:  Boll Ist Sieroter Milan       Date:  1983-05-31

9.  Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-1A2 and cold-adapted recombinant viruses in seronegative adult volunteers.

Authors:  B R Murphy; M B Rennels; R G Douglas; R F Betts; R B Couch; T R Cate; R M Chanock; A P Kendal; H F Maassab; S Suwanagool; S B Sotman; L A Cisneros; W C Anthony; D R Nalin; M M Levine
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

10.  Antigenicity and reactogenicity of influenza A/USSR/77 virus vaccine in children--a multicentered evaluation of dosage and safety.

Authors:  P F Wright; J D Cherry; H M Foy; W P Glezen; C B Hall; K McIntosh; A S Monto; R H Parrott; B Portnoy; L H Taber
Journal:  Rev Infect Dis       Date:  1983 Jul-Aug
View more
  1 in total

1.  Simultaneous influenza and pneumococcal vaccination in elderly individuals.

Authors:  G Grilli; L Fuiano; L R Biasio; F Pregliasco; A Plebani; M Leibovitz; A G Ugazio; F Vacca; M L Profeta
Journal:  Eur J Epidemiol       Date:  1997-04       Impact factor: 8.082

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.